Alder Biopharmaceuticals Inc. (ALDR) announced after the bell Tuesday that Randall C. Schatzman has stepped down as President, Chief Executive Officer and as a director. Board member Paul B. Cleveland has been appointed as interim President and CEO.
from RTT - Before the Bell http://ift.tt/2DLY4TB
via IFTTT
No comments:
Post a Comment